Author:
Martinez Chanza Nieves,Werner Lillian,Plimack Elizabeth,Yu Evan Y.,Alva Ajjai S.,Crabb Simon J.,Powles Thomas,Rosenberg Jonathan E.,Baniel Jack,Vaishampayan Ulka N.,Berthold Dominik R.,Ladoire Sylvain,Hussain Syed A.,Milowsky Matthew I.,Agarwal Neeraj,Necchi Andrea,Pal Sumanta K.,Sternberg Cora N.,Bellmunt Joaquim,Galsky Matthew D.,Harshman Lauren C.
Funder
National Cancer Institute
Subject
Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery
Reference30 articles.
1. NCCN guidelines insights: bladder cancer version 5;Flaig;J Natl Compr Canc Netw,2018
2. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration;Advanced Bladder Cancer (ABC) Meta-analysis Collaboration;Eur Urol,2005
3. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;International Collaboration of Trialists, Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group) European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group;J Clin Oncol,2011
4. Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates;Choueiri;J Clin Oncol,2014
5. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity;Plimack;J Clin Oncol,2014
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献